お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
975585

抗ウイルス薬療法の世界市場:機会と戦略(2030年までの予測)COVID-19の影響と成長

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications and Growth

出版日: | 発行: The Business Research Company | ページ情報: 英文 257 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
抗ウイルス薬療法の世界市場:機会と戦略(2030年までの予測)COVID-19の影響と成長
出版日: 2020年12月11日
発行: The Business Research Company
ページ情報: 英文 257 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界の抗ウイルス薬療法市場について調査しており、市場規模や予測、動向や戦略、成長および抑制要因、COVID-19の影響、薬剤クラス・用途・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構造

第6章 イントロダクション

  • 地域別セグメンテーション
  • 薬剤クラス別セグメンテーション
  • 用途別セグメンテーション

第7章 市場の特徴

  • 市場の定義
  • 医薬品クラス別市場セグメンテーション
    • DNA(ヌクレオチド)ポリメラーゼ阻害剤
    • 逆転写酵素阻害剤
    • プロテアーゼ阻害剤
    • ノイラミニダーゼ阻害剤
    • その他
  • 用途別市場セグメンテーション
    • HIV
    • 肝炎
    • ヘルペス
    • インフルエンザ
    • その他

第8章 市場の動向と戦略

  • ウイルス性疾患の併用薬物療法
  • 戦略的提携と合意
  • 世界の調査イニシアチブと資金提供
  • 3Dバイオプリンティングテクノロジー
  • パイプライン研究と医薬品開発件数の増加

第9章 COVID-19の影響

  • バックグラウンド
  • 薬物療法
  • 抗ウイルスレムデシビル市場の成長

第10章 市場規模と成長

  • 市場規模
  • 市場の成長実績:売上(2015-2019)
    • 市場成長要因
    • 市場抑制要因
  • 市場の成長予測:売上(2019-2023、2025F、2030F)

第11章 市場分析:地域/国別

  • 市場実績・予測:地域別売上(2015-2019、2023F、2025F、2030F)
  • 市場実績・予測:国別売上(2015-2019、2023F、2025F、2030F)

第12章 市場セグメンテーション

  • 市場実績・予測:薬剤クラス別売上(2015-2019、2023F、2025F、2030F)
  • 市場実績・予測:用途別売上(2015-2019、2023F、2025F、2030F)

第13章 アジア太平洋地域市場

第14章 西欧市場

第15章 東欧市場

第16章 北米市場

第17章 南米市場

第18章 中東市場

第19章 アフリカ市場

第20章 競合情勢

  • 企業プロファイル
  • Gilead Sciences Inc
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.

第21章 主な合併と買収

  • MerckとRidgeback Bioの協業
  • Gilead:Novartisから3つの抗ウイルスポートフォリオの取得
  • Johnson&Johnson:Novira Therapeutics, Inc.の買収
  • Johnson&Johnson:Aliosの買収

第22章 市場の将来展望と潜在的分析

  • 2023年の市場:最も新しい機会を提供する国
  • 2023年の市場:最も新しい機会を提供するセグメント
  • 2023年の市場:成長戦略
    • 市場動向ベースの戦略
    • 競合他社の戦略

第23章 結論・提言

  • 結論
  • 提言

第24章 付録

目次

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global anti-viral drug therapy market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the anti-viral drug therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global anti-viral drug therapy market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by drug class, by application.

Market Characteristics - The market characteristics section of the report defines and explains the anti-viral drug therapy market. This chapter also defines and describes goods and related services covered in the report.

Trends And Strategies - This chapter describes the major trends shaping the global anti-viral drug therapy market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of COVID-19 - This section describes the impact of COVID-19 on the anti-viral drug therapy market.

Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2015-2030) and analysis for different segments.

Regional Market Size and Growth - This section contains the region's market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global anti-viral drug therapy market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Future Outlook and Potential Analysis - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for anti-viral drug therapy companies in terms of product offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Markets Covered:

The global anti-viral drug therapy market is segmented into -

By Drug Class: DNA (Nucleotide) Polymerase Inhibitors; Reverse Transcriptase Inhibitors; Protease Inhibitors; Neuraminidase Inhibitors; Others

By Application: HIV; Hepatitis; Herpes; Influenza; Others

Companies Mentioned: Gilead Sciences Inc.; GlaxoSmithKline plc; Johnson & Johnson; AbbVie Inc.; Merck & Co., Inc.

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Anti-Viral Drug Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Drug Class
    • 6.1.3. Segmentation By Application

7. Anti-Viral Drug Therapy Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Drug Class
    • 7.2.1. DNA (Nucleotide) Polymerase Inhibitors
    • 7.2.2. Reverse Transcriptase Inhibitors
    • 7.2.3. Protease Inhibitors
    • 7.2.4. Neuraminidase Inhibitors
    • 7.2.5. Others
  • 7.3. Market Segmentation By Application
    • 7.3.1. HIV
    • 7.3.2. Hepatitis
    • 7.3.3. Herpes
    • 7.3.4. Influenza
    • 7.3.5. Others

8. Anti-Viral Drug Therapy Market Trends And Strategies

  • 8.1. Combination Drug Therapy For Viral Diseases
  • 8.2. Strategic Collaborations And Agreements
  • 8.3. Global Research Initiatives And Funding
  • 8.4. 3D Bioprinting Technology
  • 8.5. Increasing Number Of Pipeline Studies And Drug Development

9. Impact Of COVID-19 On Anti-Viral Drug Therapy Market

  • 9.1. Background
  • 9.2. Drug Therapies
  • 9.3. Antiviral Remdesivir Market Growth

10. Global Anti-Viral Drug Therapy Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2015 - 2019
    • 10.2.2. Restraints On The Market 2015 - 2019
  • 10.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 10.3.1. Drivers Of The Market 2019 - 2023
    • 10.3.2. Restraints On The Market 2019 - 2023

11. Anti-Viral Drug Therapy Market, Regional And Country Analysis

  • 11.1. Global Anti-Viral Drug Therapy Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 11.2. Global Anti-Viral Drug Therapy Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)

12. Global Anti-Viral Drug Therapy Market Segmentation

  • 12.1. Global Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 12.2. Global Anti-Viral Drug Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Anti-Viral Drug Therapy Market

  • 13.1. Asia Pacific Anti-Viral Drug Therapy Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Market Information
    • 13.1.3. COVID-19 Impact
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investments
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.3. Asia-Pacific Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.4. Asia-Pacific Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.5. Asia-Pacific Anti-Viral Drug Therapy Market: Country Analysis
  • 13.6. China Anti-Viral Drug Therapy Market
  • 13.7. China Anti-Viral Drug Therapy Market Overview
    • 13.7.1. Country Information
    • 13.7.2. Market Information
    • 13.7.3. COVID-19 Impact
    • 13.7.4. Background Information
    • 13.7.5. Government Initiatives
    • 13.7.6. Regulations
    • 13.7.7. Regulatory Bodies
    • 13.7.8. Major Associations
    • 13.7.9. Taxes levied
    • 13.7.10. Corporate Tax Structure
    • 13.7.11. Investments
    • 13.7.12. Major Companies
  • 13.8. China Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.9. China Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.10. China Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.11. Australia Anti-Viral Drug Therapy Market
  • 13.12. Australia Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.13. Australia Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.14. Australia Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.15. India Anti-Viral Drug Therapy Market
  • 13.16. India Anti-Viral Drug Therapy Market Overview
    • 13.16.1. Country Information
    • 13.16.2. Market Information
    • 13.16.3. COVID-19 Impact
    • 13.16.4. Background Information
    • 13.16.5. Government Initiatives
    • 13.16.6. Regulations
    • 13.16.7. Regulatory Bodies
    • 13.16.8. Major Associations
    • 13.16.9. Taxes levied
    • 13.16.10. Corporate Tax Structure
    • 13.16.11. Investments
    • 13.16.12. Major Companies
  • 13.17. India Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.18. India Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.19. India Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.20. Indonesia Anti-Viral Drug Therapy Market
  • 13.21. Indonesia Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.22. Indonesia Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.23. Indonesia Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.24. Japan Anti-Viral Drug Therapy Market
  • 13.25. Japan Anti-Viral Drug Therapy Market Overview
    • 13.25.1. Country Information
    • 13.25.2. Market Information
    • 13.25.3. COVID-19 Impact
    • 13.25.4. Background Information
    • 13.25.5. Government Initiatives
    • 13.25.6. Regulations
    • 13.25.7. Regulatory Bodies
    • 13.25.8. Major Associations
    • 13.25.9. Taxes levied
    • 13.25.10. Corporate Tax Structure
    • 13.25.11. Investments
    • 13.25.12. Major Companies
  • 13.26. Japan Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.27. Japan Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.28. Japan Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.29. South Korea Anti-Viral Drug Therapy Market
  • 13.30. South Korea Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.31. South Korea Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.32. South Korea Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

14. Western Europe Anti-Viral Drug Therapy Market

  • 14.1. Western Europe Anti-Viral Drug Therapy Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Market Information
    • 14.1.3. COVID-19 Impact
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investments
    • 14.1.12. Major Companies
  • 14.2. Western Europe Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.3. Western Europe Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.4. Western Europe Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.5. Western Europe Anti-Viral Drug Therapy Market: Country Analysis
  • 14.6. UK Anti-Viral Drug Therapy Market
  • 14.7. UK Anti-Viral Drug Therapy Market Overview
    • 14.7.1. Country Information
    • 14.7.2. Market Information
    • 14.7.3. COVID-19 Impact
    • 14.7.4. Background Information
    • 14.7.5. Government Initiatives
    • 14.7.6. Regulations
    • 14.7.7. Regulatory Bodies
    • 14.7.8. Major Associations
    • 14.7.9. Taxes levied
    • 14.7.10. Corporate Tax Structure
    • 14.7.11. Investments
    • 14.7.12. Major Companies
  • 14.8. UK Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.9. UK Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.10. UK Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.11. France Anti-Viral Drug Therapy Market
  • 14.12. France Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.13. France Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.14. France Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.15. Germany Anti-Viral Drug Therapy Market
  • 14.16. Germany Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.17. Germany Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.18. Germany Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Anti-Viral Drug Therapy Market

  • 15.1. Eastern Europe Anti-Viral Drug Therapy Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Market Information
    • 15.1.3. COVID-19 Impact
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Tax Levied
    • 15.1.9. Associations
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.3. Eastern Europe Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.4. Eastern Europe Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.5. Eastern Europe Anti-Viral Drug Therapy Market: Country Analysis
  • 15.6. Russia Anti-Viral Drug Therapy Market
  • 15.7. Russia Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.8. Russia Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.9. Russia Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

16. North America Anti-Viral Drug Therapy Market

  • 16.1. North America Anti-Viral Drug Therapy Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Market Information
    • 16.1.3. COVID-19 Impact
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Major Associations
    • 16.1.9. Taxes levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investments
    • 16.1.12. Major Companies
  • 16.2. North America Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 16.3. North America Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.4. North America Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.5. North America Anti-Viral Drug Therapy Market: Country Analysis
  • 16.6. USA Anti-Viral Drug Therapy Market
  • 16.7. USA Anti-Viral Drug Therapy Market Overview
    • 16.7.1. Country Information
    • 16.7.2. Market Information
    • 16.7.3. COVID-19 Impact
    • 16.7.4. Background Information
    • 16.7.5. Government Initiatives
    • 16.7.6. Regulations
    • 16.7.7. Regulatory Bodies
    • 16.7.8. Major Associations
    • 16.7.9. Corporate Tax Structure
    • 16.7.10. Investments
    • 16.7.11. Major Companies
  • 16.8. USA Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 16.9. USA Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.10. USA Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

17. South America Anti-Viral Drug Therapy Market

  • 17.1. South America Anti-viral Drug Therapy Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. COVID-19 Impact
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Tax Levied
    • 17.1.9. Associations
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. South America Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.3. South America Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.4. South America Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.5. South America Anti-Viral Drug Therapy Market: Country Analysis
  • 17.6. Brazil Anti-Viral Drug Therapy Market
  • 17.7. Brazil Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.8. Brazil Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.9. Brazil Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Middle East Anti-Viral Drug Therapy Market

  • 18.1. Middle East Anti-Viral Drug Therapy Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. COVID-19 Impact
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Major Associations
    • 18.1.8. Taxes Levied
    • 18.1.9. Corporate Tax Structure
    • 18.1.10. Investment
    • 18.1.11. Major Companies
  • 18.2. Middle East Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.3. Middle East Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.4. Middle East Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Africa Anti-Viral Drug Therapy Market

  • 19.1. Africa Anti-Viral Drug Therapy Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. COVID-19 Impact
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Taxes Levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Corporate Tax Structure
    • 19.1.12. Major Companies
  • 19.2. Africa Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.3. Africa Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.4. Africa Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Global Anti-Viral Drug Therapy Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Gilead Sciences Inc
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. GlaxoSmithKline plc
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Johnson & Johnson
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial Overview
  • 20.5. AbbVie Inc.
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial overview
  • 20.6. Merck & Co., Inc.
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview

21. Anti-Viral Drug Therapy Market, Key Mergers And Acquisitions

  • 21.1. Merck and Ridgeback Bio Collaborate
  • 21.2. Gilead Acquired Three Antiviral Portfolios From Novartis
  • 21.3. Johnson & Johnson Acquired Novira Therapeutics, Inc.
  • 21.4. Johnson & Johnson Acquired Alios

22. Anti-Viral Drug Therapy Market Future Outlook and Potential Analysis

  • 22.1. Global Anti-Viral Drug Therapy Market In 2023 - Countries Offering Most New Opportunities
  • 22.2. Global Anti-Viral Drug Therapy Market In 2023 - Segments Offering Most New Opportunities
  • 22.3. Global Anti-Viral Drug Therapy Market In 2023 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Anti-Viral Drug Therapy Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Place
    • 23.2.3. Price
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.